Browse Category

Financial News News 8 October 2025 - 9 October 2025

TSMC Stock Tops $300 as AI Chip Boom Fuels Rally – Can It Keep Climbing? (Oct 2025 Update)

TSMC Stock Tops $300 as AI Chip Boom Fuels Rally – Can It Keep Climbing? (Oct 2025 Update)

Overview: TSMC’s Business and Recent Performance Taiwan Semiconductor Manufacturing Co. (TSMC) is the world’s largest contract chipmaker – a pure-play” foundry that fabricates advanced semiconductors for clients like Apple, NVIDIA, AMD and more ts2.tech. Rather than selling its own chips, TSMC builds chips to order, focusing on cutting-edge manufacturing processes. This model has made TSMC a pillar of global tech supply chains, commanding an estimated 60%+ market share of the overall foundry market (and over 90% in the most advanced nodes) ts2.tech. In effect, TSMC manufactures ~90% of the world’s most advanced processors, putting it at the heart of technologies
Inside Deutsche Börse & Frankfurt Stock Exchange: Europe’s Financial Powerhouse Unveiled (2025 Update)

Inside Deutsche Börse & Frankfurt Stock Exchange: Europe’s Financial Powerhouse Unveiled (2025 Update)

Deutsche Börse AG: Structure, Divisions & Subsidiaries Deutsche Börse AG is the backbone of Germany’s capital markets infrastructure. Founded in 1992 as a joint-stock company, it has grown into a multinational marketplace organizer for securities trading and related services en.wikipedia.org. The group’s structure spans the entire trade lifecycle: Frankfurt Stock Exchange (FWB): History, Market Structure & Trading Platforms The Frankfurt Stock Exchange – Frankfurter Wertpapierbörse (FWB) – is the crown jewel of Deutsche Börse Group and the epicenter of German equity trading. It traces its origins back to 16th-century trade fairs and has operated as a formal exchange since 1585,
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Stock Price & Recent Performance Costco’s stock has been on a steady long-term climb, and 2025 has been no exception – albeit with some twists. The shares currently hover around $914–$928 (as of Oct 9, 2025) stockanalysis.com. That price is roughly where Costco started the year, meaning the stock is about flat year-to-date after accounting for dividends. However, this flat YTD performance masks considerable volatility along the way. In the first half of 2025, Costco rallied strongly with the broader market. The stock peaked at an intraday all-time high of about $1,078 earlier this year ts2.tech, as enthusiasm around Costco’s
9 October 2025
Gerresheimer Stock in Freefall After Another Profit Warning – Is the Worst Over?

Gerresheimer Stock in Freefall After Another Profit Warning – Is the Worst Over?

Gerresheimer’s Profit Warning Shocks Investors Gerresheimer AG – a supplier of specialty packaging (from glass vials and jars to medical devices like injector pens) – delivered yet another profit warning for 2025, stunning investors. Late on October 8, the Düsseldorf-based firm announced it would abandon its previous annual guidance after third-quarter results came in far below expectations reuters.com reuters.com. CEO Dietmar Siemssen was candid about the shortfall: The operative performance of our business in the first nine months is clearly below our expectations,” he admitted finanzen.at. As a result, Gerresheimer’s board withdrew its prior targets and issued gloomier new forecasts for the full year boersen-zeitung.de boersen-zeitung.de.
Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Historical Evolution: From Paris Bourse to Euronext Paris Euronext Paris traces its origins back over 300 years. The exchange was formally established by royal decree in 1724, making it one of the oldest in the world en.wikipedia.org. Throughout the 19th and 20th centuries, the Paris Bourse (as it was known) was France’s central marketplace for stocks and bonds. It operated via open-outcry trading on the floor of the Palais Brongniart well into the 1980s en.wikipedia.org. By 1986, Paris began shifting to electronic trading, introducing a system called CAC (Continuous Assisted Trading) which fully automated quotations by 1989 en.wikipedia.org. This early
Stimulus Check October 2025: Rumors Debunked – What to Know as Shutdown Continues

Stimulus Check October 2025: Rumors Debunked – What to Know as Shutdown Continues

No New Federal Stimulus – Confirmed by IRS and Congress Despite hopeful chatter online, federal authorities have made clear that there is no new stimulus check approved for October 2025. Any nationwide payment to taxpayers would require a law passed by Congress and signed by the President – and that hasn’t happened. Congress has not passed any 2025 stimulus package,” and the IRS has flatly stated that Americans will not receive any new stimulus money this month ts2.tech. All official announcements (whether from the IRS, Treasury, or White House) consistently show no plans for a fourth stimulus round ts2.tech. Multiple
London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

History and Structure of the London Stock Exchange Founded over 300 years ago, the London Stock Exchange has a rich heritage. It began informally in 1698 when John Castaing, a London broker, first published stock and commodity prices at Jonathan’s Coffee House investopedia.com. By 1801, stockbrokers seeking a more orderly market created a regulated exchange with membership rules and fees – marking the birth of the modern LSE investopedia.com. Throughout the 19th and 20th centuries, the exchange grew alongside the British Empire and industrial revolution, listing companies from around the world. Major reforms shaped its development: for example, the Big Bang” deregulation in
Amazon’s Finance Teams Unleash AI for Complex Tasks – Transforming Corporate Finance

Amazon Stock Surges on New AI Push – Latest Price, Key News & 2025 Outlook

Stock Price & Recent Performance (October 2025) As of October 8, 2025, Amazon’s stock trades around $225 per share stockanalysis.com. It has risen modestly in early October, bouncing from about $219 at the start of the month to the mid-$220s range stockanalysis.com. This week’s ~1.5% uptick follows a period of volatility in late September. Year-to-date, AMZN is roughly flat to slightly up (low single-digit percentage gains), lagging the broader S&P 500 and most other Magnificent Seven” tech giants. Notably, Amazon hit an all-time high near $242 in early February 2025, but a summer tech sell-off and profit-taking pulled the stock down about 10% from that
Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Stock Performance: The 2025 Rollercoaster Ride Xenetic’s stock was relatively quiet for most of 2025 until early October, when it suddenly erupted. By Oct 8, 2025, XBIO had skyrocketed to levels not seen in years. On that day alone, the stock soared 123% to $9.58 (from a prior $4.29 close) finanzen.ch, after touching intraday highs well above $10. This move extended a remarkable run from under $3.50 at the start of the week to nearly $12-13 intraday on Oct 8 ainvest.com. In fact, at one point XBIO was up about +195% in a single session according to real-time trackers timothysykes.com. Such gains are extraordinary – even by
Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Above Food Ingredients Inc. is a Canadian plant-based food tech company that went public via SPAC merger in 2024 stocktwits.com. In 2025, its stock ABVE has been on a wild ride – climbing from penny-stock levels to over $4, an almost 8-fold increase in under a year marketbeat.com. This meteoric rise comes as Above Food pivots beyond organic grains into gold-backed cryptocurrencies and next-gen financial tech, capturing investor imagination. Below, we dive into Above Food’s mission, business model, financials, stock performance, forecasts, expert commentary, strategic moves, ESG profile, and the latest news driving this micro-cap’s buzz. Company Background and Mission Founded in Regina, Saskatchewan, in 2023, Above Food began with a
Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Company Overview: Operations & Business Model Cipher Mining Inc. is a pure-play Bitcoin miner operating industrial-scale data centers with a focus on ultra-low-cost power ts2.tech. The company strategically locates its facilities in regions with cheap, renewable-rich electricity (e.g. West Texas), often building behind-the-meter or adjacent to wind and solar farms ts2.tech ts2.tech. Its flagship Black Pearl” site near Odessa, TX is a 150 MW facility designed for both Bitcoin mining and high-performance computing (HPC) workloads ts2.tech. As of mid-2025, Cipher’s deployed hashrate reached about 16.8 EH/s (exahashes per second), using next-gen ASIC machines for high energy efficiency ts2.tech. The company had aggressively expanded capacity – a 2.6 GW development pipeline of power projects
Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Therapy (Target) Indication Status (2025) Current Ownership TECELRA(afamitresgene, targets MAGE-A4) Synovial sarcoma (unresectable/metastatic) FDA approved Aug 2024 biospace.com; ~16 patients treated in launch year nasdaq.com. Sold to US WorldMeds (2025) adaptimmune.com Letetresgene (lete-cel, NY-ESO-1) MRCLS and synovial sarcoma (advanced solid tumors) Phase II completed (42% response rate) stocktitan.net; FDA Breakthroughdesignation in 2025 stocktitan.net; BLA filing planned for 2025. Sold to US WorldMeds (2025) adaptimmune.com Uzatresegene (uza-cel, next-gen TCR) Solid tumors (MAGE-A4 TCR, partnered with Galapagos) Preclinical/IND-enabling stage; partnership deal $665M signed 2024 fiercebiotech.com. Sold to US WorldMeds (2025) adaptimmune.com PRAME-targeted TCR Multiple cancers (PRAME antigen) Preclinical (IND-enabling on hold to cut costs) biospace.com. Retained by Adaptimmune adaptimmune.com CD70-targeted TCR Hematologic malignancies
8 October 2025
1 83 84 85 86 87 94
Go toTop